sixty-five previously untreated patients ( 34 women , 31 men ) with acute myelocytic leukemia , ranging in age from 15 to 71 ( median 43 ) years , were treated for remission induction with 7-day courses of cytarabine ( 100 mg/m2/day continuous i.v . infusion ) together with daunorubicin ( 45 mg/m2/day rapid i.v . injection ) on days 1 , 2 and 3 .
C0023467
acute
C0011015
daunorubicin